GENENTECH, INC for GENENTECH INC

Trade (domestic/foreign) TRD

Issues related to international trade.

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Taxation/Internal Revenue Code TAX

Tax reform issues -- international and domestic

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS)

Copyright/Patent/Trademark CPT

General IP Issues. Transpacific Partnership Agreement. Patent Litigation Reform. Intellectual Property and Process Patent Issues. Implementation of P.L. 108-173,

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Health Issues HCR

FY 2017 Labor, Health and Human Services, Education and Related Agencies Appropriations annual spending bill; Influenza antiviral allotment with the Centers for Disease Control Strategic National Stockpile issues concerning implementation of Patient Protection and Affordable Care Act Drug pricing H.R. 6, the 21st Century Cures Act Innovations for Healthier Americas Moonshot initiative Precision Medicine Implementation of issues related to Pharmaceutical Quality Security Accountability Act Issues related supply chain Drug safety and pedigree issues Issues related to the 340B program Issues related to follow on biologics

Contacted: Food & Drug Administration (FDA); SENATE; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 6 (114th)

Medicare/Medicaid MMM

Payment policies for prescription drugs. Implementation of Medicare pharmaceutical coverage and reimbursement, 340B Program, dual eligible demonstrations, Medicare Part B reimbursement for physicians, and related provisions of the Affordable Care Act. Reimbursement adequacy and patient access issues associated with potential CMMI implementation of the proposed Medicare Part B Drug Payment Model.

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

FY 2017 Labor, Health and Human Services, Education and Related Agencies Appropriations annual spending bill; Influenza antiviral allotment with the Centers for Disease Control Strategic National Stockpile Issues related to establishing the budget for the United States Government for fiscal year 2017 Budget/Labor HHS Appropriations Act, FY2017 Bipartisan Budget Act of 2015 Issues related to FDA and HHS program funding in the FY16 Labor, Health and Human Services, and Education and Related Agencies. FY16 Agriculture, Rural Developments, Food and Drug Administration and Related Agencies Appropriations bills

Contacted: Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES